Thomas I. H. Dubin
Board Member
Intensity Therapeutics, Inc. (INTS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas I. H. Dubin
Thomas I. H. Dubin is recorded as Board Member at Intensity Therapeutics, Inc. (INTS). Intensity Therapeutics, Inc. reported in an 8-K filed July 17, 2024 that Thomas I. H. Dubin was appointed Class I director, effective July 17, 2024. Intensity Therapeutics, Inc. reported in an 8-K filed May 15, 2024 that Thomas I. H. Dubin was appointed Class I director, effective May 14, 2024.
“The election of two Class I directors, each to hold office until the 2027 annual meeting of stockholders or until their respective successor is elected and qualified.”
“On May 14, 2024, the Board of Directors (the “Board”) of Intensity Therapeutics, Inc. (the “Company”) increased the size of the Board from four directors to five and appointed Thomas I. H. Dubin to the Board as a Class I director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Intensity Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Lewis H. Bender CEO
- Joseph Talamo CFO
- Daniel Donovan Board Member
- Emer Leahy Board Member
- Mark A. Goldberg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.